These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30685649)

  • 1. Compounds commonly used in equine medicine inhibits the voltage-gated potassium channel K
    Calloe K; Rognant S; Friis S; Shaughnessy C; Klaerke DA; Trachsel D
    Res Vet Sci; 2019 Apr; 123():239-246. PubMed ID: 30685649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Cloning and Functional Expression of the Equine K+ Channel KV11.1 (Ether à Go-Go-Related/KCNH2 Gene) and the Regulatory Subunit KCNE2 from Equine Myocardium.
    Pedersen PJ; Thomsen KB; Olander ER; Hauser F; Tejada Mde L; Poulsen KL; Grubb S; Buhl R; Calloe K; Klaerke DA
    PLoS One; 2015; 10(9):e0138320. PubMed ID: 26376488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of drug interaction with the Kv11.1 potassium channel.
    Hill AP; Perrin MJ; Heide J; Campbell TJ; Mann SA; Vandenberg JI
    Mol Pharmacol; 2014 May; 85(5):769-76. PubMed ID: 24586056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature Effects on Kinetics of KV11.1 Drug Block Have Important Consequences for In Silico Proarrhythmic Risk Prediction.
    Windley MJ; Mann SA; Vandenberg JI; Hill AP
    Mol Pharmacol; 2016 Jul; 90(1):1-11. PubMed ID: 27190211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of trimethoprim-sulfadiazine and detomidine on the function of equine K
    Trachsel DS; Tejada MA; Groesfjeld Christensen V; Pedersen PJ; Kanters JK; Buhl R; Calloe K; Klaerke DA
    J Vet Pharmacol Ther; 2018 Aug; 41(4):536-545. PubMed ID: 29566261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization.
    Perry MD; Ng CA; Mangala MM; Ng TYM; Hines AD; Liang W; Xu MJO; Hill AP; Vandenberg JI
    Cardiovasc Res; 2020 Jul; 116(8):1434-1445. PubMed ID: 31628797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.
    Guo L; Guthrie H
    J Pharmacol Toxicol Methods; 2005; 52(1):123-35. PubMed ID: 15936217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol-Dependent Differences in IC
    Lee W; Windley MJ; Perry MD; Vandenberg JI; Hill AP
    Mol Pharmacol; 2019 May; 95(5):537-550. PubMed ID: 30770456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A place for high-throughput electrophysiology in cardiac safety: screening hERG cell lines and novel compounds with the ion works HTTM system.
    Guthrie H; Livingston FS; Gubler U; Garippa R
    J Biomol Screen; 2005 Dec; 10(8):832-40. PubMed ID: 16234341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological analysis of mammalian cells expressing hERG using automated 384-well-patch-clamp.
    Haraguchi Y; Ohtsuki A; Oka T; Shimizu T
    BMC Pharmacol Toxicol; 2015 Dec; 16():39. PubMed ID: 26671227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A High-Throughput Screening Assay to Identify Drugs that Can Treat Long QT Syndrome Caused by Trafficking-Deficient K
    Egly CL; Blackwell DJ; Schmeckpeper J; Delisle BP; Weaver CD; Knollmann BC
    Mol Pharmacol; 2022 Apr; 101(4):236-245. PubMed ID: 35125346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and functional expression of the K
    Pedersen PJ; Thomsen KB; Flak JB; Tejada MA; Hauser F; Trachsel D; Buhl R; Kalbfleisch T; DePriest MS; MacLeod JN; Calloe K; Klaerke DA
    Res Vet Sci; 2017 Aug; 113():79-86. PubMed ID: 28917093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The [3H]dofetilide binding assay is a predictive screening tool for hERG blockade and proarrhythmia: Comparison of intact cell and membrane preparations and effects of altering [K+]o.
    Diaz GJ; Daniell K; Leitza ST; Martin RL; Su Z; McDermott JS; Cox BF; Gintant GA
    J Pharmacol Toxicol Methods; 2004; 50(3):187-99. PubMed ID: 15519905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel K
    Kozek KA; Glazer AM; Ng CA; Blackwell D; Egly CL; Vanags LR; Blair M; Mitchell D; Matreyek KA; Fowler DM; Knollmann BC; Vandenberg JI; Roden DM; Kroncke BM
    Heart Rhythm; 2020 Dec; 17(12):2180-2189. PubMed ID: 32522694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome.
    Amorós I; Jiménez-Jáimez J; Tercedor L; Barana A; Gómez R; de la Fuente MG; Dolz-Gaitón P; Alvarez M; Martínez-Espín E; Lorente JA; Melgares R; Tamargo J; Delpón E; Caballero R
    Heart Rhythm; 2011 Mar; 8(3):463-70. PubMed ID: 21109023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rescue of protein expression defects may not be enough to abolish the pro-arrhythmic phenotype of long QT type 2 mutations.
    Perry MD; Ng CA; Phan K; David E; Steer K; Hunter MJ; Mann SA; Imtiaz M; Hill AP; Ke Y; Vandenberg JI
    J Physiol; 2016 Jul; 594(14):4031-49. PubMed ID: 26958806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliable identification of cardiac liability in drug discovery using automated patch clamp: Benchmarking best practices and calibration standards for improved proarrhythmic assessment.
    Brinkwirth N; Takasuna K; Doi M; Becker N; Obergrussberger A; Friis S; Furukawa H; Hasegawa Y; Oka T; Ohtsuki A; Fertig N; Stoelzle-Feix S
    J Pharmacol Toxicol Methods; 2020 Sep; 105():106884. PubMed ID: 32565325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
    Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
    Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis and drug sensitivity of the delayed rectifier (IKr) in the fish heart.
    Hassinen M; Haverinen J; Vornanen M
    Comp Biochem Physiol C Toxicol Pharmacol; 2015; 176-177():44-51. PubMed ID: 26215639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.